In silico and in vivo studies of gp120-HIV-derived peptides in complex with G4-PAMAM dendrimers

RSC Advances(2020)

Cited 0|Views2
No score
Abstract
Novel synthetic vaccines as immunotherapy approaches for HIV are interesting strategies that imply big challenges as they increase the poor immunogenic properties of peptide epitopes and their structural damage from the physiological environment.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined